Revised: June 4, 2024
Enacted: April 1, 2020
Keimyung Medical Journal (KMJ) reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. The next step is to check for plagiarism or duplication through a similarity check, after confirmation that no ethical violations have been detected, it is peer reviewed by at least two anonymous reviewers selected by the editors. The authors’ names and affiliations are removed during the double-blind peer review.
Acceptance of a manuscript is based on the critiques and recommendations of the reviewers. An initial decision will normally be made within three weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. If choosing to proceed, the corresponding author must indicate all revisions that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within four weeks of the editorial decision is regarded as a withdrawal. If a revision extension period is required, the author should contact the editorial office.
The editorial board notifies the results of the manuscript's deliberation to the corresponding author in one of the following types: accept, minor revision, major revision or reject.
As all editors and Editorial Board members at the KMJ are active professionals and researchers, it may happen that they would want to submit their articles to the KMJ. This represents a potential conflict of interest, especially in cases of submissions from decision-making editors. In reviewing submissions from its editors and Editorial Board members, the KMJ follows the guidelines for good editorial practice set by international editorial organizations, such as World Association of Medical Editors (WAME; http://www.wame.org/resources/publication-ethics-policies-for-medicaljournals#conflicts) and Committee on Publication Ethics (COPE; http://publicationethics.org/case/editor-author-ownjournal).
The review of such manuscripts will be processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts although they are commissioned ones.